NANETS produces a weekly publication, Weekly Net Connection. It contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!

The Pancreas Journal of Neuroendocrine Tumors and Pancreatic Diseases and Sciences has published the North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma in the April 2021 issue. Members can access these guidelines by logging in as a member and accessing Pancreas Journal.

These guidelines represent the latest work from NANETS' Guidelines Committee, led by Lauren Fishbein, MD, PhD, MTR, Chair, Janice Pasieka, MD, Co-Chair, and Jennifer Chan, MD, MPH, Past Chair. Since 2013, NANETS has published ten guidelines.

"NANETS consensus guidelines on metastatic pheo/para were created to provide guidance in the diagnosis and treatment of these rare tumours. This comprehensive document was designed to fill in the current gaps in the field and identified areas for future clinical and translational research," said Dr. Pasieka.

"Guidelines on how to treat and monitor those with metastatic pheochromocytoma/paraganglioma were lacking. The NANETS initiative to create an expert consensus guideline on this rare disease topic serves to inform and guide physicians from multiple disciplines on the various treatment options and best practices," noted Dr. Fishbein.

Access to these and other Pancreas articles is a benefit of being a NANETS member. Visit our membership page to join today.
Authors Include: Lauren Fishbein, MD, PhD; Jaydira Del Rivero, MD; Tobias Else, MD; James R. Howe, MD; Sylvia L. Asa, MD; Debbie L. Cohen, MD; Patricia L.M. Dahia, MD, PhD; Douglas L. Fraker, MD; Karyn A. Goodman, MD; Thomas A. Hope, MD; Pamela L. Kunz, MD; Kimberly Perez, MD; Nancy D. Perrier, MD; Daniel A. Pryma, MD; Mabel Ryder, MD; Aaron R. Sasson, MD; Michael C. Soulen, M; and Camilo Jimenez, MD.

Click to access Pheo Para Guidelines.

NANETS and SNMMI collaborated to deliver a dynamic webinar on PRRT. Moderated by Ghassan El-Haddad, MD, this event featured keynote speakers Elcin Zan, MD and Ryan Reddy, MD, who spoke on PRRT principles and patient selection, patient outcomes with Lu-177 DOTATATE and future directions.

 NANETS NetMed Webinars     

Over 200 people attended the event, which included participation in the evaluation component and earning up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) maintenance of Certification (MOC) program.

A post presentation survey will be sent to all who registered for the webinar. Please complete and return it to NANETS for future educational planning purposes.

NANETS member Po Hien Ear, PhD, Research Assistant Professor in Surgical Oncology and Endocrine Surgery at the University of Iowa, Carver College of Medicine, was the recipient of NANETS' 2019 Basic/Translational Science Investigator (BTSI) award.

Po Hien Ear

"The NANETS BTSI award has given me the opportunity to secure a faculty position at the University of Iowa. It really made a huge difference in my academic career," Dr. Ear remarked. "My research has been extremely fruitful because of the funding provided by this award."
As she continues to prepare her manuscripts, she expects that her papers will be published within the next year. Dr. Ear previously authored the Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids.

"I am extremely proud and honored to be a NANETS member. I have never had the opportunity to be part of such a supportive and collaborative society. I really appreciate the initiatives of NANETS' administrative and executive committees for organizing the Women in NETs and Research Grants webinars."

NANETS is proud to count Dr. Jimenez and Dr. Ear among our members. We welcome healthcare professionals across disciplines and specialties to join our medical society. Learn more about the benefits of membership and join today.